Madrigal Pharmaceuticals (MDGL) is back in focus after releasing real world data on its MASH drug Rezdiffra at The Liver Meeting in Denver and reporting a swing to third quarter net income. The recent...
Source LinkMadrigal Pharmaceuticals (MDGL) is back in focus after releasing real world data on its MASH drug Rezdiffra at The Liver Meeting in Denver and reporting a swing to third quarter net income. The recent...
Source Link
Comments